|
|
|
Volumn 3, Issue 2, 2003, Pages 93-94
|
|
Antiplatelet and anticoagulent agents in cardiovascular disease: Basic research and clinical applications. Foreword
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ADENOSINE DIPHOSPHATE;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CELECOXIB;
CLOPIDOGREL;
COUMARIN;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DIPYRIDAMOLE;
DRUG METABOLITE;
EPTIFIBATIDE;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
GLYCOPROTEIN IB;
PLATELET ADENOSINE DIPHOSPHATE RECEPTOR P2Y 12;
PURINE P2Y RECEPTOR;
ROFECOXIB;
SALICYLATE SODIUM;
THROMBIN;
THROMBOCYTE RECEPTOR;
THROMBOPLASTIN;
TICLOPIDINE;
TIROFIBAN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VON WILLEBRAND FACTOR;
XIMELAGATRAN;
ANTICOAGULATION;
ATHEROSCLEROTIC PLAQUE;
BLEEDING;
CARDIOVASCULAR DISEASE;
CELL INTERACTION;
CORONARY STENT;
COVALENT BOND;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG TARGETING;
DRUG UTILIZATION;
EDITORIAL;
ENDOTHELIUM CELL;
ENZYME ACTIVITY;
HEART INFARCTION;
HEART INFARCTION SIZE;
HEART MUSCLE ISCHEMIA;
HEART PROTECTION;
HIGH RISK PATIENT;
HUMAN;
LOW DRUG DOSE;
MICROVASCULATURE;
NONHUMAN;
PATHOPHYSIOLOGY;
PROGNOSIS;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
REGULATORY MECHANISM;
REPERFUSION INJURY;
RISK ASSESSMENT;
SECONDARY PREVENTION;
THROMBOCYTE ADHESION;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOGENESIS;
THROMBOSIS PREVENTION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
|
|
EID: 0041473410
PISSN: 15289648
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
